February 09, 2022
Back Page
42
2
Digital disruption is poised to usher in a new era of customer-centricity and efficiency, starting with trials and precision targeting.
February 09, 2022
Features
42
2
Our latest CEO Leadership roundtable focused on the most top-of-mind issues for companies.
February 09, 2022
Features
42
2
Designing an omnichannel artificial intelligence ecosystem that integrates strategies can boost commercial success for pharma.
February 09, 2022
Features
42
2
Pharma should take an integrated approach to representing cultural elements in materials.
February 09, 2022
Features
42
2
Industry embraces modern approach to commercialization, but keeps human connection at center.
February 09, 2022
Executive Profile
42
2
Ted Schroeder, CEO of Nabriva Therapeutics, is passionate in his forward-thinking approach to finding the next generation of anti-infectives, as resistance to least-expensive, tried-and-true therapies continues to grow.
February 09, 2022
Finance
42
2
Biopharma stock performance continues to struggle.
February 09, 2022
Managed Markets
42
2
Payers not looking to favor one product.
February 09, 2022
Technology
42
2
Spurred on by COVID-19 and companies’ evolving digital maturity, AI looks set to gain a real foothold in pharma’s promotional activities.
February 09, 2022
Leadership
42
2
Addressing whole employee is as important as treating whole patient.
February 09, 2022
Global Report
42
2
European Commission looks to relieve issues without legislation.
February 09, 2022
Issue PDF
42
2
Click the title above for a link to open the Pharmaceutical Executive February 2022 issue in an interactive PDF format.
January 24, 2022
Washington Report
42
2
International collaboration needed to address distribution hurdles.